These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 34985762

  • 1. Chronic myelomonocytic leukemia: 2022 update on diagnosis, risk stratification, and management.
    Patnaik MM, Tefferi A.
    Am J Hematol; 2022 Mar 01; 97(3):352-372. PubMed ID: 34985762
    [Abstract] [Full Text] [Related]

  • 2. Chronic Myelomonocytic leukemia: 2020 update on diagnosis, risk stratification and management.
    Patnaik MM, Tefferi A.
    Am J Hematol; 2020 Jan 01; 95(1):97-115. PubMed ID: 31736132
    [Abstract] [Full Text] [Related]

  • 3. Chronic myelomonocytic leukemia: 2018 update on diagnosis, risk stratification and management.
    Patnaik MM, Tefferi A.
    Am J Hematol; 2018 Jun 01; 93(6):824-840. PubMed ID: 29878489
    [Abstract] [Full Text] [Related]

  • 4. Chronic myelomonocytic leukemia: 2016 update on diagnosis, risk stratification, and management.
    Patnaik MM, Tefferi A.
    Am J Hematol; 2016 Jun 01; 91(6):631-42. PubMed ID: 27185207
    [Abstract] [Full Text] [Related]

  • 5. Chronic myelomonocytic leukemia: 2024 update on diagnosis, risk stratification and management.
    Patnaik MM, Tefferi A.
    Am J Hematol; 2024 Jun 01; 99(6):1142-1165. PubMed ID: 38450850
    [Abstract] [Full Text] [Related]

  • 6. Chronic Myelomonocytic Leukemia: a Genetic and Clinical Update.
    McCullough KB, Patnaik MM.
    Curr Hematol Malig Rep; 2015 Sep 01; 10(3):292-302. PubMed ID: 26122388
    [Abstract] [Full Text] [Related]

  • 7. Chronic Myelomonocytic Leukemia: Focus on Clinical Practice.
    Patnaik MM, Tefferi A.
    Mayo Clin Proc; 2016 Feb 01; 91(2):259-72. PubMed ID: 26848006
    [Abstract] [Full Text] [Related]

  • 8. Chronic myelomonocytic leukemia: 2013 update on diagnosis, risk stratification, and management.
    Parikh SA, Tefferi A.
    Am J Hematol; 2013 Nov 01; 88(11):967-74. PubMed ID: 23963888
    [Abstract] [Full Text] [Related]

  • 9. Cytogenetic and molecular abnormalities in chronic myelomonocytic leukemia.
    Patnaik MM, Tefferi A.
    Blood Cancer J; 2016 Feb 05; 6(2):e393. PubMed ID: 26849014
    [Abstract] [Full Text] [Related]

  • 10. Atypical chronic myeloid leukemia and myelodysplastic/myeloproliferative neoplasm, not otherwise specified: 2023 update on diagnosis, risk stratification, and management.
    Patnaik MM, Tefferi A.
    Am J Hematol; 2023 Apr 05; 98(4):681-689. PubMed ID: 36601682
    [Abstract] [Full Text] [Related]

  • 11. Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: a focused review.
    Patnaik MM, Lasho T.
    Hematology Am Soc Hematol Educ Program; 2020 Dec 04; 2020(1):460-464. PubMed ID: 33275673
    [Abstract] [Full Text] [Related]

  • 12. Chronic myelomonocytic leukemia: 2012 update on diagnosis, risk stratification, and management.
    Parikh SA, Tefferi A.
    Am J Hematol; 2012 Jun 04; 87(6):610-9. PubMed ID: 22615103
    [Abstract] [Full Text] [Related]

  • 13. How I diagnose and treat chronic myelomonocytic leukemia.
    Patnaik MM.
    Haematologica; 2022 Jul 01; 107(7):1503-1517. PubMed ID: 35236051
    [Abstract] [Full Text] [Related]

  • 14. Current management of patients with chronic myelomonocytic leukemia.
    Alfonso A, Montalban-Bravo G, Garcia-Manero G.
    Curr Opin Oncol; 2017 Jan 01; 29(1):79-87. PubMed ID: 27849645
    [Abstract] [Full Text] [Related]

  • 15. Targeted deep sequencing improves outcome stratification in chronic myelomonocytic leukemia with low risk cytogenetic features.
    Palomo L, Garcia O, Arnan M, Xicoy B, Fuster F, Cabezón M, Coll R, Ademà V, Grau J, Jiménez MJ, Pomares H, Marcé S, Mallo M, Millá F, Alonso E, Sureda A, Gallardo D, Feliu E, Ribera JM, Solé F, Zamora L.
    Oncotarget; 2016 Aug 30; 7(35):57021-57035. PubMed ID: 27486981
    [Abstract] [Full Text] [Related]

  • 16. Prognostic score including gene mutations in chronic myelomonocytic leukemia.
    Itzykson R, Kosmider O, Renneville A, Gelsi-Boyer V, Meggendorfer M, Morabito M, Berthon C, Adès L, Fenaux P, Beyne-Rauzy O, Vey N, Braun T, Haferlach T, Dreyfus F, Cross NC, Preudhomme C, Bernard OA, Fontenay M, Vainchenker W, Schnittger S, Birnbaum D, Droin N, Solary E.
    J Clin Oncol; 2013 Jul 01; 31(19):2428-36. PubMed ID: 23690417
    [Abstract] [Full Text] [Related]

  • 17. DNMT3A mutations are associated with inferior overall and leukemia-free survival in chronic myelomonocytic leukemia.
    Patnaik MM, Barraco D, Lasho TL, Finke CM, Hanson CA, Ketterling RP, Gangat N, Tefferi A.
    Am J Hematol; 2017 Jan 01; 92(1):56-61. PubMed ID: 27733013
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Oligomonocytic chronic myelomonocytic leukemia (chronic myelomonocytic leukemia without absolute monocytosis) displays a similar clinicopathologic and mutational profile to classical chronic myelomonocytic leukemia.
    Geyer JT, Tam W, Liu YC, Chen Z, Wang SA, Bueso-Ramos C, Oak J, Arber DA, Hsi E, Rogers HJ, Levinson K, Bagg A, Hassane DC, Hasserjian RP, Orazi A.
    Mod Pathol; 2017 Sep 01; 30(9):1213-1222. PubMed ID: 28548124
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.